期刊文献+

骨肉瘤干细胞的研究现状与进展 被引量:2

下载PDF
导出
摘要 骨肉瘤是最常见的骨原发性恶性肿瘤,好发于儿童及青少年患者。目前其细胞及分子发病机制尚不明确。随着肿瘤干细胞理论的发展,越来越多的研究证实骨肉瘤干细胞与肿瘤的侵袭、转移、复发及耐药之间也存在联系。因此,本文就骨肉瘤干细胞的存在证据与来源、分选与鉴定方法、小生态环境(niche)以及骨肉瘤干细胞与耐药间的关系的研究进展做一综述。
出处 《西部医学》 2012年第5期1027-1029,共3页 Medical Journal of West China
基金 国家重点基础研究发展计划(973计划)(课题编号2010CB529402)
  • 相关文献

参考文献21

  • 1Heare T, Hensley MA. Bone tumors: osteosarcoma and Ewing's sarcoma[J]. Curr Opin Pediatr, 2009, 21: 365-372.
  • 2Makino S. The role of tumor stem cells in regrowth of the tumor following drastic applications[J]. Acta Unio Iat Contra Cancrum, 1959, 15 (Suppl 1):196-198.
  • 3Ischenko I, Seeliger H, Schaffer M, et al. Cancer stem cells: how can we target them[J]. Curt Med Chem, 2008, 15:3171- 3184.
  • 4Tang C, Ang BT, Pervaiz S. Cancer stem cell: target for anticancer therapy[J]. FASEB J, 2007, 21:3777-3785.
  • 5Lapidot T, Sirard C, Vormoor J, et al. A eell initiating human acute myeloid leukaemia after transplantation into SCID mice [J]. Nature, 1994, 367:645-648.
  • 6Gibbs CP, Kukekov VG, Reith JD, et al. Stem-like cells in bone sarcomas: implications for tumorigenesis [J]. Neoplasia, 2005, 7:967-976.
  • 7Fujii H, Honoki K, Tsujiuehi T, et al. Sphereforming stem-like eell populations with drug resistance in human sarcoma cell lines [J]. Int J Oncol, 2009, 34:1381-1386.
  • 8Wilson H, Huelsmeyer M, Chun R, etal. Isolation and characterisation of cancer stem ceils from canine osteosarcoma[J]. Vet J, 2008, 175:69-75.
  • 9Miura M, Miura Y, Padilla-Nash HM, et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation[J]. Stem Cells, 2006, 24:1095-1103.
  • 10Di Fiore R, Santulli A, Ferrante RD, et al. Identification and expansion of human osteosareoma-eancer-stem ceils by long-term 3-aminobenzamide treatment[J]. J Cell Physiol, 2009, 219: 301-313.

同被引文献53

  • 1张兴泰.下肢骨肉瘤术后存活17年1例报告[J].西部医学,2005,17(6):619-619. 被引量:1
  • 2欧阳振,王栓科,康学文,王翠芳,汪静,郭洪章.人骨肉瘤细胞株U2-OS中分离并鉴定肿瘤干细胞[J].中国组织工程研究与临床康复,2007,11(24):4706-4709. 被引量:6
  • 3Tang N,Song WX,Luo J. Osteosarcoma development and stem cel differentiation[J].Clinical Orthopaedics and Related Research,2008,(09):2114-2130.doi:10.1007/s11999-008-0335-z.
  • 4Lewis IJ,Nooij MA,Whelan J. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy:a randomized phase III trial of the European Osteosarcoma Intergroup[J].JOURNAL OF THE NATIONAL CANCER INSTITUTE,2007,(02):112-128.doi:10.1093/jnci/djk015.
  • 5Meyers PA,Schwartz CL,Krailo MD. Osteosarcoma:the addition of muramyl tripeptide to chemotherapy improves overal survival--a report from the Children's Oncology Group[J].Journal of Clinical Oncology,2008,(04):633-638.doi:10.1200/JCO.2008.14.0095.
  • 6Kansara M,Thomas DM. Molecular pathogenesis of osteosarcoma[J].DNA Cel Biol,2007,(01):1-18.
  • 7Pittenger MF,Mackay AM,Beck SC. Multilineage potential of adult human mesenchymal stem cel s[J].SCIENCE,1999,(5411):143-147.doi:10.1126/science.284.5411.143.
  • 8Wang L,Park P,Lin CY. Characterization of stem cel attributes in human osteosarcoma cel lines[J].CANCER BIOLOGY & THERAPY,2009,(06):543-552.
  • 9Tirino V,Desiderio V,d'Aquino R. Detection and characterization of CD133+ cancer stem cel s in human solid tumours[J].PLoS One,2008,(10):e3469.
  • 10Gibbs CP,Kukekov VG,Reith JD. Stem-like cel s in bone sarcomas:implications for tumorigenesis[J].Neoplasia,2005,(11):967-976.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部